Evidence map›Paper›PMID 33982426›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2021

Hyperpolarized MRI with silicon micro and nanoparticles: Principles and applications.

Shivanand Pudakalakatti, José S Enriquez, Caitlin McCowan, Saleh Ramezani, Jennifer S Davis, Niki M Zacharias, Dontrey Bourgeois, Pamela E Constantinou, Daniel A Harrington, Daniel Carson and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Advances in nanoprobes for molecular MRI of Alzheimer's disease.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Shivanand PudakalakattiDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
José S EnriquezDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Caitlin McCowanDepartment of Electrical and Computer Engineering, Rice University, Houston, Texas, USA.
Saleh RamezaniMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Jennifer S DavisDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Niki M ZachariasMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Dontrey BourgeoisDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pamela E ConstantinouDepartment of BioSciences, Rice University, Houston, Texas, USA.
Daniel A HarringtonMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Daniel CarsonDepartment of BioSciences, Rice University, Houston, Texas, USA.
Mary C Farach-CarsonMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Pratip K BhattacharyaDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-0625-252X
The University of Texas MD Anderson Cancer Center · USRice University · USThe University of Texas Health Science Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Training Program in Biostatistics for Cancer ResearchT32CA096520 · NCI · RICE UNIVERSITY · PI KIMMEL, MAREK, YUAN, YING · 2003 to 2023
$4.5M
Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer DetectionR21EB031217 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BHATTACHARYA, PRATIP K. · 2021 to 2023
$648k
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon NanoparticlesR21CA185536 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BHATTACHARYA, PRATIP K. · 2014 to 2015
$383k
NCI NIH HHS P30 CA016672NCI NIH HHS R21 CA185536NCI NIH HHS T32 CA096520NIBIB NIH HHS R21 EB031217
6 · The paper itself

Abstract

Silicon-based micro and nanoparticles are ideally suited for use as biomedical imaging agents because of their biocompatibility, biodegradability, and simple surface chemistry that facilitates drug loading and targeting. A method to hyperpolarize silicon particles using dynamic nuclear polarization (DNP), which increases magnetic resonance (MR) imaging signals by several orders-of-magnitude through enhanced nuclear spin alignment, was developed to allow silicon particles to function as contrast agents for in vivo magnetic resonance imaging. In this review, we describe the application of the DNP technique to silicon particles and nanoparticles for background-free real-time molecular MR imaging. This review provides a summary of the state-of-the-science in silicon particle hyperpolarization with a detailed protocol for hyperpolarizing silicon particles. This information will foster awareness and spur interest in this emerging area of nanoimaging and provide a path to new developments and discoveries to further advance the field. This article is categorized under: Diagnostic Tools > In Vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies.

Indexed as

NanoparticlesSiliconContrast MediaMagnetic Resonance ImagingNanomedicineContrast MediaSilicon29Si MRIhyperpolarizationmicroparticlesmolecular imagingnanomedicinenanoparticlesNMRtargeted imaging

Identifiers

PMID33982426
PMCPMC9352437
OpenAlexW3163566444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.